Eris Lifesciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Sep ' 20

Sales

821.00

684.13

586.77

628.96

564.85

Operating profit

299.99

267.24

224.41

259.59

219.95

Interest

13.39

14.71

1.74

1.25

0.41

Gross profit

297.61

262.05

237.55

272.44

223.36

EPS (Rs)

16.80

15.50

14.03

16.66

14.19

Other income

11.00

9.53

14.89

14.10

3.82

Stock adjustment

-28.20

2.63

-5.23

7.72

-11.74

Raw material

54.81

63.51

63.22

54.35

55.19

Power and fuel

-

-

-

-

-

Employee expenses

171.46

130.14

107.87

114.31

106.73

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

322.94

220.62

196.51

192.99

194.72

Provisions made

-

-

-

-

-

Depreciation

45.16

30.88

28.61

22.85

18.27

Taxation

23.89

20.38

18.18

23.16

12.47

Net profit / loss

228.55

210.79

190.76

226.43

192.62

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

13.60

13.60

13.59

13.59

13.58

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

36.54

39.06

38.24

41.27

38.94

GPM (%)

35.77

37.78

39.48

42.37

39.28

NPM (%)

27.47

30.39

31.71

35.21

33.87